Drugs / AL-37807
Trials 4 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00620256 | Nov 2007 → Jul 2008 | ocular hypertension, open-angle glaucoma | Alcon Research | Completed | No outcome recorded |
| Phase 2 | NCT00465621 | Mar → Jul 2007 | ocular hypertension, open-angle glaucoma | Alcon Research | Completed | No outcome recorded |
| Phase 2 | NCT00372931 | May 2006 → Aug 2007 | ocular hypertension, open-angle glaucoma | Alcon Research | Completed | No outcome recorded |
| Phase 2 | NCT00287521 | Nov 2005 → Feb 2006 | ocular hypertension, open-angle glaucoma | Alcon Research | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AL-37807 | “AL-37807 Ophthalmic Solution 0.05%, 0.1% and 0.2% dosed QD AM” NCT00465621 ↗ |
| Route | Other | “One drop in the study eye(s) once daily for 28 days” NCT00287521 ↗ |